The lap-band device dramatically reduces the size of a patient's stomach, and as such, it can be effective for weight loss in very obese patients. It offers at least one major advantage over gastric bypass surgery, in that the lap-band can be removed. But can the lap-band procedure also be safe and effective for patients who are even slightly obese, or do the potential risks outweigh the benefits for these patients? Dr. Diana Zuckerman, president of the National Research Center for Women & Families and its cancer prevention and treatment fund in Washington, D.C., discusses the criteria for patients to receive lap-banding. What concerns surround the issue of lowering the body-mass index (or BMI) threshold for patients eligible for this procedure? What are the long-term risks of lap-bands? Dr. Maurice Pickard hosts.
Which Patients Should be Eligible for Lap-Bands?
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
The lap-band device dramatically reduces the size of a patient's stomach, and as such, it can be effective for weight loss in very obese patients. It offers at least one major advantage over gastric bypass surgery, in that the lap-band can be removed. But can the lap-band procedure also be safe and effective for patients who are even slightly obese, or do the potential risks outweigh the benefits for these patients? Dr. Diana Zuckerman, president of the National Research Center for Women & Families and its cancer prevention and treatment fund in Washington, D.C., discusses the criteria for patients to receive lap-banding. What concerns surround the issue of lowering the body-mass index (or BMI) threshold for patients eligible for this procedure? What are the long-term risks of lap-bands? Dr. Maurice Pickard hosts.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
IgG4-RD Case Conversations: Diagnosing Pancreaticobiliary Manifestations and Ruling Out Malignancy
Updates From the 7th World Symposium Task Force
New Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure
A Practical Guide to Prescribing in HF
Clinical Conundrums in ARIA: Nuances of Microhemorrhages when Evaluating an MRI for ARIA
The Importance of PD-L1 Testing: Shaping the Future of Treatment in ESCC
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?